SEMATECH and International SEMATECH Manufacturing Initiative (ISMI) will highlight current research through a wide range of lectures and workshop sessions from July 13-15, in conjunction with SEMICON West 2010 in San Francisco, CA.
Demonstrating its extensive knowledge base for today's demanding back-end wafer level processes, DEK's presence at the upcoming Semicon West event in San Francisco, California will feature the Galaxy print platform with Wafer Transport Solution.
Cadence Design Systems, Inc. today announced that Innofidei Inc., a leading mobile chipset provider based in Beijing, China, has successfully taped out the industry's first long-term evolution time division duplex (LTE-TDD, or TD-LTE) baseband chip supporting a bandwidth of 20MHz for the next-generation TD-CDMA wireless communications protocol.
Based on its recent analysis of the nanomaterial encapsulation technology market, Frost and Sullivan recognizes Vive Nano with the 2010 North American Frost and Sullivan Award for Technology Innovation for a unique encapsulation technology to synthesize nanoparticles.
Contour Energy Systems, Inc. an innovative portable power company commercializing next-generation battery systems, today announced a new limited subsidiary in the United Kingdom that will provide the company a strategic presence in advance of the rollout of new commercial battery systems in Europe.
Picosun Oy, Finland-based global manufacturer of state-of-the-art Atomic Layer Deposition (ALD) systems today launched its latest ALD systems product, Picoplatform, in connection with the 10th International Conference on Atomic Layer Deposition, which was opened today in Seoul, the Republic of Korea.
WaferGen Biosystems, Inc., a leading developer of state-of-the-art genetic analysis systems, has announced that scientists from Kyoto University will use the WaferGen SmartChip Real-Time PCR System to identify and compare biomarkers to advance their research to regenerate tissues such as bone, cartilage, and muscle, lost or reduced due to various causes.
Officials at NanoBioMagnetics announced today that the company has been awarded a Phase I Small Business Innovative Research (SBIR) grant from the National Science Foundation to study the effectiveness of magnetically vectored therapeutics in the treatment of locally advanced breast cancers (LABC).